Mechanistic Interplay Between Multiple Myeloma and Severe SARS-CoV-2 Infection: Therapeutic Promise of Mesenchymal Stem Cell-Derived Extracellular Vesicles.

Leyfman Y, Ikkurthy N, Dohadwala TK, Coloma HS, Ghazal J, Joshi M, Cortiana V, Pasnoor DS, Menon GP, Levi N, Balasubramanian M, Park C

Open source

DOI
10.3390/biomedicines14071617
Published
2026 Jul 17
Container
Biomedicines
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/biomedicines14071617,
  title = {Mechanistic Interplay Between Multiple Myeloma and Severe SARS-CoV-2 Infection: Therapeutic Promise of Mesenchymal Stem Cell-Derived Extracellular Vesicles.},
  author = {Leyfman Y and Ikkurthy N and Dohadwala TK and Coloma HS and Ghazal J and Joshi M and Cortiana V and Pasnoor DS and Menon GP and Levi N and Balasubramanian M and Park C},
  year = {2026},
  journal = {Biomedicines},
  doi = {10.3390/biomedicines14071617},
  url = {https://doi.org/10.3390/biomedicines14071617}
}

RIS

TY  - JOUR
TI  - Mechanistic Interplay Between Multiple Myeloma and Severe SARS-CoV-2 Infection: Therapeutic Promise of Mesenchymal Stem Cell-Derived Extracellular Vesicles.
AU  - Leyfman Y
AU  - Ikkurthy N
AU  - Dohadwala TK
AU  - Coloma HS
AU  - Ghazal J
AU  - Joshi M
AU  - Cortiana V
AU  - Pasnoor DS
AU  - Menon GP
AU  - Levi N
AU  - Balasubramanian M
AU  - Park C
PY  - 2026
JO  - Biomedicines
DO  - 10.3390/biomedicines14071617
UR  - https://doi.org/10.3390/biomedicines14071617
ER  - 

APA

Y, L., N, I., TK, D., HS, C., J, G., M, J., V, C., DS, P., GP, M., N, L., M, B., & C, P. (2026). Mechanistic Interplay Between Multiple Myeloma and Severe SARS-CoV-2 Infection: Therapeutic Promise of Mesenchymal Stem Cell-Derived Extracellular Vesicles.. Biomedicines. https://doi.org/10.3390/biomedicines14071617

Source records